The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Phospho Tau(181P) Assay Kit Market Research Report 2025
Synopsis
Many studies at home and abroad have shown that plasma pTau-181 can be used as an early biomarker of Alzheimer's disease (AD), effectively distinguishing neurodegenerative diseases of AD dementia and non-AD dementia, but due to the influence of blood Due to the limitations of the brain barrier, the concentration of brain-derived proteins in peripheral blood is low, and they are easily interfered by plasma matrix proteins. The traditional ELISA method or chemiluminescence method cannot obtain ideal detection results.
Global Human Phospho Tau(181P) Assay Kit market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Phospho Tau(181P) Assay Kit market research.
Key manufacturers engaged in the Human Phospho Tau(181P) Assay Kit industry include Roche Diagnostics, Abcam, Fujirebio, Immuno-Biological Laboratories, Biorbyt, IBL-America, RayBiotech, Assay Genie and Novus Biologicals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Human Phospho Tau(181P) Assay Kit were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human Phospho Tau(181P) Assay Kit market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Phospho Tau(181P) Assay Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Diagnostics
Abcam
Fujirebio
Immuno-Biological Laboratories
Biorbyt
IBL-America
RayBiotech
Assay Genie
Novus Biologicals
LifeSpan BioSciences
BioVendor Laboratory Medicine
Lychix Bio
Adanti
Shanghai Sig Biotechnology
Wuhan Fine Biotech
Segment by Type
ELISA
Chemiluminescence Method
Segment by Application
AD Dementia
Non-AD Dementia
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Phospho Tau(181P) Assay Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Many studies at home and abroad have shown that plasma pTau-181 can be used as an early biomarker of Alzheimer's disease (AD), effectively distinguishing neurodegenerative diseases of AD dementia and non-AD dementia, but due to the influence of blood Due to the limitations of the brain barrier, the concentration of brain-derived proteins in peripheral blood is low, and they are easily interfered by plasma matrix proteins. The traditional ELISA method or chemiluminescence method cannot obtain ideal detection results.
Global Human Phospho Tau(181P) Assay Kit market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Phospho Tau(181P) Assay Kit market research.
Key manufacturers engaged in the Human Phospho Tau(181P) Assay Kit industry include Roche Diagnostics, Abcam, Fujirebio, Immuno-Biological Laboratories, Biorbyt, IBL-America, RayBiotech, Assay Genie and Novus Biologicals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Human Phospho Tau(181P) Assay Kit were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human Phospho Tau(181P) Assay Kit market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Phospho Tau(181P) Assay Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Diagnostics
Abcam
Fujirebio
Immuno-Biological Laboratories
Biorbyt
IBL-America
RayBiotech
Assay Genie
Novus Biologicals
LifeSpan BioSciences
BioVendor Laboratory Medicine
Lychix Bio
Adanti
Shanghai Sig Biotechnology
Wuhan Fine Biotech
Segment by Type
ELISA
Chemiluminescence Method
Segment by Application
AD Dementia
Non-AD Dementia
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Phospho Tau(181P) Assay Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Human Phospho Tau(181P) Assay Kit Market Overview
1.1 Product Overview and Scope of Human Phospho Tau(181P) Assay Kit
1.2 Human Phospho Tau(181P) Assay Kit Segment by Type
1.2.1 Global Human Phospho Tau(181P) Assay Kit Market Value Comparison by Type (2023-2029)
1.2.2 ELISA
1.2.3 Chemiluminescence Method
1.3 Human Phospho Tau(181P) Assay Kit Segment by Application
1.3.1 Global Human Phospho Tau(181P) Assay Kit Market Value by Application: (2023-2029)
1.3.2 AD Dementia
1.3.3 Non-AD Dementia
1.4 Global Human Phospho Tau(181P) Assay Kit Market Size Estimates and Forecasts
1.4.1 Global Human Phospho Tau(181P) Assay Kit Revenue 2018-2029
1.4.2 Global Human Phospho Tau(181P) Assay Kit Sales 2018-2029
1.4.3 Global Human Phospho Tau(181P) Assay Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Phospho Tau(181P) Assay Kit Market Competition by Manufacturers
2.1 Global Human Phospho Tau(181P) Assay Kit Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Phospho Tau(181P) Assay Kit Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Phospho Tau(181P) Assay Kit Average Price by Manufacturers (2018-2023)
2.4 Global Human Phospho Tau(181P) Assay Kit Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Phospho Tau(181P) Assay Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Phospho Tau(181P) Assay Kit, Product Type & Application
2.7 Human Phospho Tau(181P) Assay Kit Market Competitive Situation and Trends
2.7.1 Human Phospho Tau(181P) Assay Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Phospho Tau(181P) Assay Kit Players Market Share by Revenue
2.7.3 Global Human Phospho Tau(181P) Assay Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Phospho Tau(181P) Assay Kit Retrospective Market Scenario by Region
3.1 Global Human Phospho Tau(181P) Assay Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Phospho Tau(181P) Assay Kit Global Human Phospho Tau(181P) Assay Kit Sales by Region: 2018-2029
3.2.1 Global Human Phospho Tau(181P) Assay Kit Sales by Region: 2018-2023
3.2.2 Global Human Phospho Tau(181P) Assay Kit Sales by Region: 2024-2029
3.3 Global Human Phospho Tau(181P) Assay Kit Global Human Phospho Tau(181P) Assay Kit Revenue by Region: 2018-2029
3.3.1 Global Human Phospho Tau(181P) Assay Kit Revenue by Region: 2018-2023
3.3.2 Global Human Phospho Tau(181P) Assay Kit Revenue by Region: 2024-2029
3.4 North America Human Phospho Tau(181P) Assay Kit Market Facts & Figures by Country
3.4.1 North America Human Phospho Tau(181P) Assay Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2029)
3.4.3 North America Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Phospho Tau(181P) Assay Kit Market Facts & Figures by Country
3.5.1 Europe Human Phospho Tau(181P) Assay Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2029)
3.5.3 Europe Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Phospho Tau(181P) Assay Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Human Phospho Tau(181P) Assay Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Phospho Tau(181P) Assay Kit Market Facts & Figures by Country
3.7.1 Latin America Human Phospho Tau(181P) Assay Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2029)
3.7.3 Latin America Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Phospho Tau(181P) Assay Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Phospho Tau(181P) Assay Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Phospho Tau(181P) Assay Kit Sales by Type (2018-2029)
4.1.1 Global Human Phospho Tau(181P) Assay Kit Sales by Type (2018-2023)
4.1.2 Global Human Phospho Tau(181P) Assay Kit Sales by Type (2024-2029)
4.1.3 Global Human Phospho Tau(181P) Assay Kit Sales Market Share by Type (2018-2029)
4.2 Global Human Phospho Tau(181P) Assay Kit Revenue by Type (2018-2029)
4.2.1 Global Human Phospho Tau(181P) Assay Kit Revenue by Type (2018-2023)
4.2.2 Global Human Phospho Tau(181P) Assay Kit Revenue by Type (2024-2029)
4.2.3 Global Human Phospho Tau(181P) Assay Kit Revenue Market Share by Type (2018-2029)
4.3 Global Human Phospho Tau(181P) Assay Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Phospho Tau(181P) Assay Kit Sales by Application (2018-2029)
5.1.1 Global Human Phospho Tau(181P) Assay Kit Sales by Application (2018-2023)
5.1.2 Global Human Phospho Tau(181P) Assay Kit Sales by Application (2024-2029)
5.1.3 Global Human Phospho Tau(181P) Assay Kit Sales Market Share by Application (2018-2029)
5.2 Global Human Phospho Tau(181P) Assay Kit Revenue by Application (2018-2029)
5.2.1 Global Human Phospho Tau(181P) Assay Kit Revenue by Application (2018-2023)
5.2.2 Global Human Phospho Tau(181P) Assay Kit Revenue by Application (2024-2029)
5.2.3 Global Human Phospho Tau(181P) Assay Kit Revenue Market Share by Application (2018-2029)
5.3 Global Human Phospho Tau(181P) Assay Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Corporation Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Diagnostics Human Phospho Tau(181P) Assay Kit Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Corporation Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abcam Human Phospho Tau(181P) Assay Kit Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 Fujirebio
6.3.1 Fujirebio Corporation Information
6.3.2 Fujirebio Description and Business Overview
6.3.3 Fujirebio Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fujirebio Human Phospho Tau(181P) Assay Kit Product Portfolio
6.3.5 Fujirebio Recent Developments/Updates
6.4 Immuno-Biological Laboratories
6.4.1 Immuno-Biological Laboratories Corporation Information
6.4.2 Immuno-Biological Laboratories Description and Business Overview
6.4.3 Immuno-Biological Laboratories Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Immuno-Biological Laboratories Human Phospho Tau(181P) Assay Kit Product Portfolio
6.4.5 Immuno-Biological Laboratories Recent Developments/Updates
6.5 Biorbyt
6.5.1 Biorbyt Corporation Information
6.5.2 Biorbyt Description and Business Overview
6.5.3 Biorbyt Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Biorbyt Human Phospho Tau(181P) Assay Kit Product Portfolio
6.5.5 Biorbyt Recent Developments/Updates
6.6 IBL-America
6.6.1 IBL-America Corporation Information
6.6.2 IBL-America Description and Business Overview
6.6.3 IBL-America Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.6.4 IBL-America Human Phospho Tau(181P) Assay Kit Product Portfolio
6.6.5 IBL-America Recent Developments/Updates
6.7 RayBiotech
6.6.1 RayBiotech Corporation Information
6.6.2 RayBiotech Description and Business Overview
6.6.3 RayBiotech Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 RayBiotech Human Phospho Tau(181P) Assay Kit Product Portfolio
6.7.5 RayBiotech Recent Developments/Updates
6.8 Assay Genie
6.8.1 Assay Genie Corporation Information
6.8.2 Assay Genie Description and Business Overview
6.8.3 Assay Genie Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Assay Genie Human Phospho Tau(181P) Assay Kit Product Portfolio
6.8.5 Assay Genie Recent Developments/Updates
6.9 Novus Biologicals
6.9.1 Novus Biologicals Corporation Information
6.9.2 Novus Biologicals Description and Business Overview
6.9.3 Novus Biologicals Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Novus Biologicals Human Phospho Tau(181P) Assay Kit Product Portfolio
6.9.5 Novus Biologicals Recent Developments/Updates
6.10 LifeSpan BioSciences
6.10.1 LifeSpan BioSciences Corporation Information
6.10.2 LifeSpan BioSciences Description and Business Overview
6.10.3 LifeSpan BioSciences Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.10.4 LifeSpan BioSciences Human Phospho Tau(181P) Assay Kit Product Portfolio
6.10.5 LifeSpan BioSciences Recent Developments/Updates
6.11 BioVendor Laboratory Medicine
6.11.1 BioVendor Laboratory Medicine Corporation Information
6.11.2 BioVendor Laboratory Medicine Human Phospho Tau(181P) Assay Kit Description and Business Overview
6.11.3 BioVendor Laboratory Medicine Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BioVendor Laboratory Medicine Human Phospho Tau(181P) Assay Kit Product Portfolio
6.11.5 BioVendor Laboratory Medicine Recent Developments/Updates
6.12 Lychix Bio
6.12.1 Lychix Bio Corporation Information
6.12.2 Lychix Bio Human Phospho Tau(181P) Assay Kit Description and Business Overview
6.12.3 Lychix Bio Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lychix Bio Human Phospho Tau(181P) Assay Kit Product Portfolio
6.12.5 Lychix Bio Recent Developments/Updates
6.13 Adanti
6.13.1 Adanti Corporation Information
6.13.2 Adanti Human Phospho Tau(181P) Assay Kit Description and Business Overview
6.13.3 Adanti Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Adanti Human Phospho Tau(181P) Assay Kit Product Portfolio
6.13.5 Adanti Recent Developments/Updates
6.14 Shanghai Sig Biotechnology
6.14.1 Shanghai Sig Biotechnology Corporation Information
6.14.2 Shanghai Sig Biotechnology Human Phospho Tau(181P) Assay Kit Description and Business Overview
6.14.3 Shanghai Sig Biotechnology Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Shanghai Sig Biotechnology Human Phospho Tau(181P) Assay Kit Product Portfolio
6.14.5 Shanghai Sig Biotechnology Recent Developments/Updates
6.15 Wuhan Fine Biotech
6.15.1 Wuhan Fine Biotech Corporation Information
6.15.2 Wuhan Fine Biotech Human Phospho Tau(181P) Assay Kit Description and Business Overview
6.15.3 Wuhan Fine Biotech Human Phospho Tau(181P) Assay Kit Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Wuhan Fine Biotech Human Phospho Tau(181P) Assay Kit Product Portfolio
6.15.5 Wuhan Fine Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Phospho Tau(181P) Assay Kit Industry Chain Analysis
7.2 Human Phospho Tau(181P) Assay Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Phospho Tau(181P) Assay Kit Production Mode & Process
7.4 Human Phospho Tau(181P) Assay Kit Sales and Marketing
7.4.1 Human Phospho Tau(181P) Assay Kit Sales Channels
7.4.2 Human Phospho Tau(181P) Assay Kit Distributors
7.5 Human Phospho Tau(181P) Assay Kit Customers
8 Human Phospho Tau(181P) Assay Kit Market Dynamics
8.1 Human Phospho Tau(181P) Assay Kit Industry Trends
8.2 Human Phospho Tau(181P) Assay Kit Market Drivers
8.3 Human Phospho Tau(181P) Assay Kit Market Challenges
8.4 Human Phospho Tau(181P) Assay Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
